mucopolysaccharidosis i
Showing 1 - 25 of 32
Long Term Follow-Up for RGX-111
Enrolling by invitation
- Mucopolysaccharidosis I
- No Intervention
-
Orange, California
- +2 more
Oct 25, 2023
MPS (RaDiCo Cohort) (RaDiCo-MPS)
Recruiting
- Mucopolysaccharidosis I
- +7 more
-
Angers, France
- +22 more
Sep 12, 2023
(LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX
Active, not recruiting
- Hemophilia B
- +2 more
- SB-318
- +2 more
-
Oakland, California
- +4 more
Jan 30, 2023
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Mucopolysaccharidosis I Trial in Wuhan (Laronidase)
Recruiting
- Mucopolysaccharidosis I
-
Wuhan, ChinaInvestigational Site Number :1560001
Jan 15, 2023
Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)
Recruiting
- Mucopolysaccharidosis I
- +7 more
- There is no intervention
-
San Francisco, CaliforniaUniversity of California San Francisco
Nov 9, 2022
Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human
Completed
- Mucopolysaccharidosis I
- +15 more
- Human Placental Derived Stem Cell
-
Denver, Colorado
- +2 more
Oct 24, 2022
Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Torrance (Adalimumab Injection [Humira],
Recruiting
- Mucopolysaccharidosis I
- +2 more
- Adalimumab Injection [Humira]
- Saline Solution for Injection
-
Torrance, CaliforniaThe Lundquist Institute at Harbor-UCLA Medical Center
Aug 9, 2022
Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome Trial in Rome (Aldurazyme (laronidase))
Recruiting
- Mucopolysaccharidosis I
- +3 more
- Aldurazyme (laronidase)
-
Rome, ItalyDipartimento di Scienze Pediatriche Medico - Chirurgiche e Neuro
Mar 28, 2022
Patients Who Have Received Gene Therapy Or Gene Marked Products
Recruiting
- Severe Combined Immunodeficiency
- +4 more
- Venipuncture
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 10, 2021
Mucopolysaccharidosis I, Cognitive Decline Trial in Torrance (Intrathecal recombinant human alpha iduronidase)
Terminated
- Mucopolysaccharidosis I
- Cognitive Decline
- Intrathecal recombinant human alpha iduronidase
-
Torrance, CaliforniaLos Angeles Biomedical Research Institute at Harbor-UCLA Medical
Oct 5, 2020
Mucopolysaccharidosis I, Hurler Syndrome Trial in Minneapolis (Stem Cell Transplant, Laronidase ERT)
Completed
- Mucopolysaccharidosis I
- Hurler Syndrome
- Stem Cell Transplant
- Laronidase ERT
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jul 10, 2019
Mucopolysaccharidosis I Trial in Porto Alegre (AGT-181)
Completed
- Mucopolysaccharidosis I
-
Porto Alegre, RS, BrazilHCPA - Hospital das Clinicas de Porto Alegre
Sep 16, 2018
Mucopolysaccharidosis I Trial in Porto Alegre (AGT-181)
Completed
- Mucopolysaccharidosis I
-
Porto Alegre, RS, BrazilHCPA - Hospital das Clinicas de Porto Alegre
Sep 16, 2018
Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Minneapolis (Somatropin (DNA origin))
Terminated
- Mucopolysaccharidosis I
- +2 more
- Somatropin (DNA origin)
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 6, 2018
Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Mannosidosis Trial in Minneapolis (Stem Cell Transplant, Busulfan,
Completed
- Mucopolysaccharidosis I
- +3 more
- Stem Cell Transplant
- Busulfan, Cyclophosphamide, ATG
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Mucopolysaccharidosis I Trial in United States (AGT-181 (HIRMAb-IDUA))
Unknown status
- Mucopolysaccharidosis I
- AGT-181 (HIRMAb-IDUA)
-
Oakland, California
- +5 more
Mar 3, 2017
Mucopolysaccharidosis I, Hurlers Syndrome, Hurler-Scheie Syndrome Trial in Canada, Germany, United States (rhIDU (recombinant
Completed
- Mucopolysaccharidosis I
- +2 more
- rhIDU (recombinant human-Alpha-L-Iduronidase)
- Placebo
-
New York, New York
- +3 more
Mar 19, 2015
Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome Trial in Worldwide (Aldurazyme, )
Completed
- Mucopolysaccharidosis I
- +3 more
- Aldurazyme
- placebo
-
Mobile, Alabama
- +24 more
Mar 17, 2015
Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome Trial in Brazil, Canada (Aldurazyme (Recombinant Human
Completed
- Mucopolysaccharidosis I
- +3 more
- Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
-
Florianopolis, Santa Catarina, Brazil
- +4 more
Mar 17, 2015
Mucopolysaccharidosis I, Hurler Syndrome, Hurler-Scheie Syndrome Trial in Worldwide (Aldurazyme (Recombinant Human
Completed
- Mucopolysaccharidosis I
- +3 more
- Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
-
Lyon, France
- +3 more
Mar 17, 2015